Overview

• Mellencamp shared the update on Oct. 3 during her Two T’s in a Pod episode with guest co-host Dolores Catania.
• She said she will continue immunotherapy for another year and explained her doctors typically evaluate remission at the three-year mark.
• She described feeling numb from the news and said physicians told her all tumors had continued to shrink on recent scans.
• She cautioned that treatment side effects will persist and that she remains careful because her immune system is compromised.
• Her melanoma, first diagnosed in 2022, progressed to stage 4 with brain and lung metastases, leading to surgeries, radiation and immunotherapy after a prognosis she once described as 50/50.